Search

Your search keyword '"Rigas G"' showing total 391 results

Search Constraints

Start Over You searched for: Author "Rigas G" Remove constraint Author: "Rigas G"
391 results on '"Rigas G"'

Search Results

1. Metformin-associated lactic acidosis and acute kidney injury in the era of COVID-19

5. Trimethylamine N-Oxide Levels in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

6. Metabolic Dysfunction-Associated Fatty Liver Disease in the National Health and Nutrition Examination Survey 2017–2020: Epidemiology, Clinical Correlates, and the Role of Diagnostic Scores

7. Oxidative Stress Management in Cardiorenal Diseases: Focus on Novel Antidiabetic Agents, Finerenone, and Melatonin

8. Endothelial Dysfunction in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

10. Prevalence, awareness, and control of hypertension in Greece before and after the COVID-19 pandemic: May Measurement Month survey 2019–2022

14. Opportunistic screening for hypertension: what does it say about the true epidemiology?

15. IMPACT OF COVID-19 ON THE PREVALENCE, AWARENESS AND CONTROL OF HYPERTENSION IN GREECE: MAY MEASUREMENT MONTH SURVEY 2019 VS 2022

16. Diffusive dynamics and stochastic models of turbulent axisymmetric wakes

21. Prognostic Significance of Risk Factors and Biomarkers in Patients Hospitalized for Cardiorenal Syndromes: A Pilot Study

26. COVID-19 and Kidney Disease: A Clinical Perspective

28. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

32. Overview of infections as an etiologic factor and complication in patients with vasculitides

35. Novel and Founder Pathogenic Variants in X-Linked Alport Syndrome Families in Greece

36. Novel and Founder Pathogenic Variants in X-Linked Alport Syndrome Families in Greece

40. Deux ans de traitement par sémaglutide (2,4 mg/sem) versus placebo chez l’adulte en situation de surpoids ou d’obésité : Résultats de STEP 5, étude de phase 3b

44. Two-year Effect of Semaglutide 2.4 mg vs Placebo in Adults with Overweight or Obesity: STEP 5

50. 03. Is ethnicity an appropriate measure of health care marginalization?: A systematic review and meta-analysis of the outcomes of diabetic foot ulceration in the Aboriginal population

Catalog

Books, media, physical & digital resources